A federal judge in Minnesota has granted final approval for a $2.4 million settlement between Hormel Foods and a class of commercial indirect purchasers. This settlement addresses allegations that Hormel participated in antitrust violations alongside other major players in the pork production industry.
According to a statement, the settlement resolves claims that pork producers conspired to manipulate market prices, raising costs for businesses and consumers. The legal action, part of a sprawling antitrust case, involved 27 consolidated cases and 146 parties, underscoring the scope of the allegations.
The case gained momentum after Judge John Tunheim consolidated the lawsuits in December 2022. The claims alleged that pork producers engaged in coordinated efforts to control supply and pricing, which harmed purchasers across the country.
Per a statement from the court, this settlement represents a significant milestone in the broader legal battles that have emerged within the pork industry. While Hormel denies wrongdoing, the resolution allows the company to avoid prolonged litigation and offers some relief to the affected class members.
Source: Swine Web
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan